{"id":"W7008270954","doi":"","title":"Biotech Stock News Bite - Heron Therapeutics, Inc. (Nasdaq: HRTX) Higher on Fourth Quarter and Full-Year 2023 Financial Results","year":2024,"lang":"en","type":"other","venue":"","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"","keywords":"Heron; Stock (firearms); Quarter (Canadian coin); Stock exchange","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001034694,0.0007052943,0.0005197691,0.001193334,0.001251978,0.00523829,0.0007051862,0.002938104,0.6402087],"category_scores_gemma":[0.003292196,0.0002784671,0.0006279827,0.0007337379,0.0003990894,0.001498002,0.0009997907,0.002369037,0.5280618],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00154793,"about_ca_system_score_gemma":0.003663373,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006824369,"about_ca_topic_score_gemma":0.01407619,"domain_scores_codex":[0.9991279,0.0000498548,0.00002854588,0.00007183816,0.0005554832,0.0001662553],"domain_scores_gemma":[0.9975405,0.0001816904,0.0001016369,0.0001003639,0.0009832487,0.001092611],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00002960663,0.00001871611,0.00006660545,0.00001427431,8.322656e-7,0.00001680709,0.000002078812,0.00001449467,0.00007460125,0.0006366647,0.9872945,0.01183084],"study_design_scores_gemma":[0.00002898977,0.00003086489,0.0005873721,0.00004153578,0.000001909542,0.00003670697,0.00001705467,0.000114207,0.0001911601,0.0004735025,0.9984702,0.000006389607],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"other","genre_scores_codex":[0.0006709538,0.0009616911,0.0003463998,0.01230594,0.01093547,0.00009660058,0.00971854,0.001447181,0.9635172],"genre_scores_gemma":[0.001881916,0.0005685589,0.000159389,0.002525788,0.001076453,0.00003260527,0.004106994,0.0002377513,0.9894105],"genre_candidate":"other","genre_consensus":"other","teacher_disagreement_score":0.6402087,"threshold_uncertainty_score":0.5131986,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03841431355418234,"score_gpt":0.3210228250786225,"score_spread":0.2826085115244401,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}